Dottikon ES Holding AG (DESN) - Financial and Strategic SWOT Analysis Review

 Published On: Jul, 2016 |    No of Pages: 46 |  Published By: GlobalData | Format: PDF
Request Free Sample

Dottikon ES Holding AG (DESN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the company's operations and business divisions.
- Corporate strategy Analyst's summarization of the company's business strategy.
- SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives’ employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Dottikon ES Holding AG (Dottikon) manufactures and commercializes active pharmaceutical ingredients (APIs), performance chemicals and intermediates for chemical and pharmaceutical industries. The company specializes in hazardous reactions with focus on exothermal reactions, highly reactive compounds or thermally unstable compounds or mixtures. Dottikon uses its technology and equipment to design, develop and optimize chemical processes, and scale up from kilograms to multi-tons. It also offers high-purity isosorbide dimethyl ether, which finds application in cosmetics, pharmaceutical, chemical and agricultural industries. It provides recycling and waste management services including recycling of solvents, high-temperature incineration, thermal recovery, and waste water treatment and purification. The company operates through Dottikon ES Group and has subsidiaries in Switzerland and the US. Dottikon is headquartered in Dottikon, Aargau, Switzerland.

Dottikon ES Holding AG Key Recent Developments

Jul 01, 2016: DOTTIKON ES' Shareholders Approve all Proposals of the Board of Directors
May 31, 2016: DOTTIKON ES Tenfold Increase in Net Income in Business Year 2015/16
Apr 15, 2016: DOTTIKON ES Strong Organic Sales Growth in Business Year 2015/16
Mar 11, 2016: DOTTIKON ES Major Investments and Increase in Headcount in Switzerland
Nov 27, 2015: DOTTIKON ES Further Increase in Net Sales and Net Income

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
Dottikon ES Holding AG - Key Facts 6
Dottikon ES Holding AG - Key Employees 7
Dottikon ES Holding AG - Key Employee Biographies 8
Dottikon ES Holding AG - Major Products and Services 9
Dottikon ES Holding AG - History 10
Dottikon ES Holding AG - Company Statement 11
Dottikon ES Holding AG - Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Affiliate 12
Section 2 Company Analysis 13
Dottikon ES Holding AG - Business Description 13
Dottikon ES Holding AG - Corporate Strategy 15
Dottikon ES Holding AG - SWOT Analysis 16
SWOT Analysis - Overview 16
Dottikon ES Holding AG - Strengths 16
Strength - Business Performance: Pharmaceutical Products 16
Strength - Research and Development (R&D) Capabilities 16
Strength - Technology Portfolio 16
Strength - Organic Growth 16
Dottikon ES Holding AG - Weaknesses 18
Weakness - Operations: Performance Chemicals 18
Weakness - Dependence on Few Customers 18
Dottikon ES Holding AG - Opportunities 19
Opportunity - Market Outlook: Active Pharmaceutical Ingridients (APIs) 19
Opportunity - Changing Demographics 19
Opportunity - Strategic Initiatives 19
Dottikon ES Holding AG - Threats 20
Threat - Foreign Exchange Fluctuations 20
Threat - Intense Competition 20
Threat - Stringent Regulations 20
Dottikon ES Holding AG - Key Competitors 21
Section 3 Company Financial Ratios 22
Financial Ratios - Capital Market Ratios 22
Financial Ratios - Annual Ratios 23
Performance Chart 25
Financial Performance 25
Financial Ratios - Interim Ratios 26
Financial Ratios - Ratio Charts 27
Section 4 Company's Lifesciences Financial Deals and Alliances 28
Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 28
Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 29
Dottikon ES Holding AG, Recent Deals Summary 30
Section 5 Company's Recent Developments 31
Jul 01, 2016: DOTTIKON ES' Shareholders Approve all Proposals of the Board of Directors 31
May 31, 2016: DOTTIKON ES Tenfold Increase in Net Income in Business Year 2015/16 32
Apr 15, 2016: DOTTIKON ES Strong Organic Sales Growth in Business Year 2015/16 34
Mar 11, 2016: DOTTIKON ES Major Investments and Increase in Headcount in Switzerland 35
Nov 27, 2015: DOTTIKON ES Further Increase in Net Sales and Net Income 36
Jul 03, 2015: DOTTIKON ES' Shareholders Approve all Proposals of the Board of Directors 39
May 29, 2015: DOTTIKON ES Higher Sales and Net Income 40
Section 6 Appendix 42
Methodology 42
Ratio Definitions 42
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Dottikon ES Holding AG, Key Facts 6
Dottikon ES Holding AG, Key Employees 7
Dottikon ES Holding AG, Key Employee Biographies 8
Dottikon ES Holding AG, Major Products and Services 9
Dottikon ES Holding AG, History 10
Dottikon ES Holding AG, Subsidiaries 12
Dottikon ES Holding AG, Affiliate 12
Dottikon ES Holding AG, Key Competitors 21
Dottikon ES Holding AG, Ratios based on current share price 22
Dottikon ES Holding AG, Annual Ratios 23
Dottikon ES Holding AG, Interim Ratios 26
Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 28
Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 29
Dottikon ES Holding AG, Recent Deals Summary 30
Currency Codes 42
Capital Market Ratios 42
Equity Ratios 43
Profitability Ratios 43
Cost Ratios 44
Liquidity Ratios 44
Leverage Ratios 45
Efficiency Ratios 45

List of Figures
Dottikon ES Holding AG, Performance Chart (2012 - 2016) 25
Dottikon ES Holding AG, Ratio Charts 27
Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 28
Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 29


If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.